Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 3 Interventional

High Intensity Focused Ultrasound (HIFU) Ablation System Study

ClinicalTrials.gov ID: NCT00392106

Public ClinicalTrials.gov record NCT00392106. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study of Focused Circumferential UltraSound for the Treatment of Atrial Fibrillation

Study identification

NCT ID
NCT00392106
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 3
Lead sponsor
ProRhythm, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • propafenone Drug
  • flecainide Drug
  • dofetilide Drug
  • sotolol Drug
  • Pulmonary vein ablation Device
  • Amiodarone Drug

Drug · Device

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Nov 30, 2010
Completion
May 31, 2011
Last update posted
Jun 16, 2008

2006 – 2011

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Fullerton Vascular Medical Group Fullerton California 92835
University of California, Los Angeles Los Angeles California 90095
Piedmont Hospital Atlanta Georgia 30309
Lexington Central Baptist Hospital Lexington Kentucky 40503
Johns Hopkins Hopsital Baltimore Maryland 21287
Lahey Clinic Burlington Massachusetts 01805
Beaumont Hospital Royal Oak Michigan 48220
New York University Hospital New York New York 10016
Stony Brook University Hospital Stony Brook New York 11794
Wake Forest University Health Systems Winston-Salem North Carolina 27157
Hillcrest Hospital Cleveland Ohio 44124
Cleveland Clinic Foundation Cleveland Ohio 44195
The Ohio State University Heart Center Columbus Ohio 43210
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Medical University of South Carolina Charleston South Carolina 29425
Texas Cardiac Arrhythmia Research Austin Texas 78705
University of Texas, Southwestern Dallas Texas 75390
University of Virginia Charlottesville Virginia 22903
Sentara Norfolk General Hospital Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00392106, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2008 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00392106 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →